PAR 5.36% 29.5¢ paradigm biopharmaceuticals limited..

Ann: Preliminary Results from Phase 2 MPS I Study

  1. lightbulb Created with Sketch. 851
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.